A new research seminar series centred around STEM and Medicine...Read More
The Nuclear Medicine group was established in early 2021 due to the support of the Sêr Cymru programme, and supports Welsh ambitions for a medical radionuclide production facility in the region. The production facility would provide radionuclides for use in both diagnostic and therapeutic treatments in nuclear medicine, leading to better patient outcomes across the nation and beyond.
The research is a mixture of modelling and experimental, focusing on:
1. Radionuclide production in a reactor or accelerator environment, including the development of target materials or optimising irradiation flux.
2. Radionuclide extraction and purification from irradiated targets.
3. Development of carriers for novel radionuclides like Auger emitters.
Meet the Team
Two NFI Postgraduate Researchers Receive Drapers’ Scholarship
For over a hundred years, the Drapers’ Company, one of...Read More
The Nuclear Futures Institute attends the Cambridge UK Nuclear Academics Meeting
The Nuclear Academics Meeting 2021, provided a forum for academics working...Read More
The future of medical radioisotope production in the UK, Nuclear Future article
Lee Evitts, Fiona Pearce, Simon Middleburgh, Michael Rushton and Bill...Read More
New Publication: Utilizing neutronics modelling to predict changing Pu ratios in UO₂ in the presence of Th
The Nuclear Futures Institute is very pleased to announce a...Read More
Bangor University joins Canadian Nuclear Isotope Council
Following a market study completed in March 2020, the Welsh...Read More